Butterfly Network Inc. has received FDA 510(k) clearance for the world’s first Ultrasound-on-a-Chip based imaging system, the Butterfly iQ for iPhone. The clearance covers 13 clinical applications, the broadest ever for a single ultrasound transducer. By combining almost 10 thousand sensors, 40 times more than systems costing 100 times as much, Butterfly ushers in a new era of accessible, high-performance medical imaging.

“Offering a unique blend of affordability, diagnostic versatility, and assistive intelligence, Butterfly has the potential to impact human health more profoundly than any diagnostic device since the stethoscope, invented over 200 years ago. At less than $2,000, health care providers can purchase an easy-to-use, powerful, whole-body medical imaging system that fits in their pocket,” said Dr. John Martin, Butterfly Network’s Chief Medical Officer. “By removing the barrier of price, I expect Butterfly to ultimately replace the stethoscope in the daily practice of medicine. We can now provide a diagnostic system to address the millions of children that die of pneumonia each year and the hundreds of thousands of women that die in childbirth, and these are just two examples of the impact this technology will have.”

To image the entire body, a traditional ultrasound system requires a large, expensive cart or box which connects to three or more piezoelectric-based transducers, each costing thousands to tens of thousands of dollars. Butterfly’s Ultrasound-on-a-Chip technology combines the capabilities of the typical three probes into a single ultra wide-band, 2D matrix array comprised of thousands of microelectromechanical systems (MEMS). These sensors are directly overlaid on an integrated circuit encompassing the electronics of a high-performance ultrasound system. The acoustic bandwidth and processing power available from the MEMS and electronics fusion creates unprecedented diagnostic versatility, speeds, modes, and resolutions. Moving the ultrasound machine to a chip allows it to be produced at unprecedented scales, at prices and rates of improvements that obey Moore’s law and will enable a series of future form factors.

The Butterfly iQ’s disruptively low price is enabled by breakthrough engineering and is covered by 33 issued patents uniquely melding micromachines and integrated circuits. Butterfly directly leverages the $3 trillion dollars that went into developing the global semiconductor supply chain, currently at the heart of the revolution in consumer electronics, telecommunications, computers and smartphones.

“Just as putting a camera on a semiconductor chip made photography accessible to anyone with a smartphone and putting a computer on a chip enabled the revolution in personal computing before that, Butterfly’s Ultrasound-on-a-Chip technology enables a low-cost window into the human body, making high-quality diagnostic imaging accessible to anyone,” said Dr. Jonathan Rothberg, founder and chairman of Butterfly Network. “Two thirds of the world’s population has no access to medical imaging, that’s not OK, and today our team is doing something about it. And they are just getting started.”

Butterfly Network has developed deep learning-based artificial intelligence applications that are tightly coupled to the hardware and assist clinicians with both image acquisition and interpretation.

“Deep learning and ultrasound imaging are a perfect combination,” said President Gioel Molinari. “As physicians use our devices in the field, they help improve the neural network models. The more physicians use Butterfly devices, the better they will get. Improvements to acquiring and interpreting images will ultimately enable less skilled users to reliably extract life-saving insight from ultrasound.”

Butterfly plans to release assistance and interpretation functionality in 2018 as a software add-on to the Butterfly iQ system.

Learn more at www.butterflynetwork.com.